Parnax Lab Ltd. engages in manufacturing and trading of pharmaceuticals and medicinal products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2009-09-15. The firm is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The company is also focused on the trading of pharmaceuticals and medicinal products. The firm operates through dealing in the pharmaceutical formulations segment. The company is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, highly viscous products, suspensions and others. The Company’s subsidiary is Naxpar Pharma Private Limited.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.